Value, Affordability, and Decision Making

Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.

UsingQALYsInCancer_Oct2010_BIG
Publication

Using QALYs in Cancer: Review of the Methodological Limitations

1 October 2010

Current methods for constructing quality adjusted life year (QALY) measurements may be deficient for cancer patients in three respects: descriptions of health state, valuation of health…

Cracks through the ice on a melting glacier in Alaska
Publication

Deliberative Processes in Decisions about Health Care Technologies

1 June 2009

In the UK and elsewhere, choices about how to allocate health care resources are guided not only by economic calculations, but also by social value judgments…

320 - assessment and appraisal
Publication

Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience

1 February 2009

Lower usage of cancer medicines in the UK compared to other countries has created questions, including whether the current approach by NICE to assessing cancer medicines…

317 - MedicalResearchWhat_Nov2008_BIG
Publication

Medical Research: What’s It Worth?

1 November 2008

Understanding the nature, extent and processes involved in the return on investment in medical research has been largely neglected as an area of serious scientific study.…

316 - NewGuidelines_Nov2008_BIG
Publication

New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?

1 November 2008

Australia was the first, in 1993, to make economic evaluation an important component of its decisions about reimbursement of drugs.  Since then, several jurisdictions have followed…

311 - ChallengesAndOpportunities_Aug2008
Publication

Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective

1 August 2008

This Briefing reports the discussions of a group of experts at an OHE workshop on the benefit-risk assessments of drugs. The objective was to identify how…

298 - Health_systems_performance_AL2003
Publication

Health Systems Performance Assessment

1 April 2006

Annual lecture by Christopher Murray, who speaks in the UK about the work on health systems performance assessment (HSPA) at the World Health Organization. He gives…